e-ISSN 2148-0532 DOI 10.54233 Open Access · CC BY-NC-SA 4.0 Türkçe
Endoüroloji Bülteni — Endourology Bulletin Submit Manuscript
Original Article Open Access

The role of PI-RADS version 2 in predicting the stage progression after radical prostatectomy in patients with G

Gleason skoru3+3 prostat kanseri olan hastalarda radikal prostatektomi sonrası evre ilerlemesinin öngörülmesinde PI-RADS versiyon 2’nin rolü

Issue
Volume 12 · Issue 3
Published
2020

Abstract

Objective: Gleason score (GS) is one of the most important parameters used in predicting the aggressiveness of prostate cancer. A discrepancy may be detected between the Gleason score in the TRUS prostate biopsy and the Gleason score determined after radical prostatectomy. In this study, we aimed to investigate the importance of mp-MRI features and PI-RADS V2 in predicting the progression of GS stage after radical prostatectomy in patients with GS 3+3 prostate cancer after TRUS-bx.

Material and Methods: The data of patients who were diagnosed with GS 3+3 prostate cancer after TRUSBx and underwent robot-assisted radical prostatectomy between January 2016 and January 2020 were retrospectively analyzed. The patients were divided into 2 groups as with progressive (Group 1) and not (Group 2) after surgery. The PSA level, patient age, prostate volume, PSA density, index lesion size on mpMRI, PI-RADS version 2 scores of the patients were evaluated.

Results: The mean age of 43 patients included in the study was 63.7±7.1 years. Stage progression was observed in 25 patients (58.1%) after surgery. According to the final pathology report, age, PSA density and PIRADS V2 score were found to be statistically significant in the patient group with and without prostate cancer stage progression (p˂0.05). Stage progression was observed in a total of 13 patients, 8 patients with a PI-RADS version 2 score of 4 and 5 patients with a score of 5. Although the mp-MRI index lesion size was not statistically significant between the two groups, it was larger in the group with stage progression (12.15±4.3 vs 15.69±7.6). While there was no stage progression in any of the patients who did not show extra-prostate dissemination in mp-MRI, only 3 patients with extra-prostate spread were reported.

Conclusion: We found that the mp-MRI PIRADS v2 score is important in prostate cancer stage progression.

More From This Issue